Home / Dental Professionals / Products / Bone Substitutes / vallos

vallos®

A new allograft that sets the pace for regeneration

Geistlich understands that in certain clinical situations, rapid turnover of new bone is important. That‘s why we‘re bringing you vallos® demineralized allogeneic granules and fibers that allow you to set the pace for treatment success.

With vallos® you can expect:

  • Consistent product quality1
  • Verified osteoinductive potential in every lot1
  • Vital bone after 18-20 weeks2

References:

  1. Compiled DCI Osteoinductivity Validation Summary_2020. (data on file)
  2. Robert A Wood & Brian L Mealey: J Periodontol. 2012 Mar;83(3):329-36. (Clinical Study)
  3. Piattelli M et al.: Int J Oral Maxillofac Implants 1999; 14 (6), 835-40. (Clinical Study).
  4. Sartori S et al.: Clin Oral Implants Res 2003; 14 (3), 369-72. (Clinical Study).
  5. Maiorana C et al.: Int J Periodontics Restorative Dent 2005; 25 (1), 19-25. (Clinical Study).
  6. Orsini G et al.: Oral Dis 2007; 13 (6), 586-93. (Clinical Study).
  7. Lindgren C et al.: Int J Oral Maxillofac Implants 2009; 24 (6), 1093-100. (Clinical Study).
  8. Mordenfeld A et al.: Clin Oral Implants Res 2010; 21 (9), 961-70. (Clinical Study).
  9. Serrano CA et al.: Implant Dent. 2018 Aug; 27(4):467-473. (Clinical Study).
  10. NCBI Pubmed, Month Year, Search term “Bio-Oss” (1208 hits) (Market research).
  11. Berglundh T & Lindhe J: Clin Oral Implants Res 1997; 8 (2), 117-24. (Preclincal Study).
  12. Weibrich G et al.: Mund Kiefer Gesichtschir 2000; 4 (3), 148-52. (Preclincal Study).
  13. Degidi M et al.: Oral Dis 2006; 12 (5), 469-75. (Clinical Study).
  14. Galindo-Moreno P et al.: Clin Oral Implants Res 2010; 21 (2), 221-7. (Clinical Study).
  15. Data on file, Geistlich Pharma AG, Switzerland

vallos® and vallos®f

In addition to the benefits above, vallos®f fibers also provide:

 

Extensive research and collaboration have created a partnership to bring you select allograft materials designed for clinical versatility and success. Demineralized vallos™ and vallos™f offer clinicians more options to enhance their ability to manage a variety of clinical situations.

vallos™ is available as a standalone or with Geistlich vallomix, which conveniently co-packs vallos™ and Geistlich Bio-Oss®. Together these proven products bring optimal consistency and performance in demanding clinical situations.1-16

References:

  1. Data on file, DCI Donor Services Tissue Bank
  2. Robert A Wood & Brian L Mealey: J Periodontol. 2012 Mar;83(3):329-36. (Clinical Study
  3. Muschler GF. J Bone Joint Surg Am. 1997; 79, 1699-1709
  4. Martin GJ, et. Al. Spine, 1999, 24, 637-645
  5. Piattelli M et al.: Int J Oral Maxillofac Implants 1999; 14 (6), 835-40. (Clinical Study)
  6. Sartori S et al.: Clin Oral Implants Res 2003; 14 (3), 369-72. (Clinical Study)
  7. Maiorana C et al.: Int J Periodontics Restorative Dent 2005; 25 (1), 19-25. (Clinical Study)
  8. Orsini G et al.: Oral Dis 2007; 13 (6), 586-93. (Clinical Study)
  9. Lindgren C et al.: Int J Oral Maxillofac Implants 2009; 24 (6), 1093-100. (Clinical Study)
  10. Mordenfeld A et al.: Clin Oral Implants Res 2010; 21 (9), 961-70. (Clinical Study)
  11. Serrano CA et al.: Implant Dent. 2018 Aug; 27(4):467-473. (Clinical Study)
  12. NCBI Pubmed, Month Year, Search term “Bio-Oss” (1208 hits) (Market research)
  13. Berglundh T & Lindhe J: Clin Oral Implants Res 1997; 8 (2), 117-24. (Preclincal Study)
  14. Weibrich G et al.: Mund Kiefer Gesichtschir 2000; 4 (3), 148-52. (Preclincal Study)
  15. Degidi M et al.: Oral Dis 2006; 12 (5), 469-75. (Clinical Study)
  16. Galindo-Moreno P et al.: Clin Oral Implants Res 2010; 21 (2), 221-7. (Clinical Study)

CAUTION: Federal law restricts these devices to sale by or on the order of a dentist or physician.

Downloads
Geistlich Product Portfolio Brochure
vallos™ Brochure

Alternative location found

You current location seems to be: Unknown

Would you like to proceed to https://www.geistlich-pharma.com ?